Recent Updates
Recently added Catalysts
PLSE Positive Sentiment

Pulse Biosciences to Present at Piper Sandler 38th Annual Healthcare Conference

Key Takeaway: Pulse Biosciences, Inc. will present at the Piper Sandler 38th Annual Healthcare Conference on December 3 at 8:50 am ET. The presentation will be available via a live and recorded webcast on the company's investor website. The company aims to leverage its proprietary nano-PFA technology to enhance healthcare outcomes.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in a significant healthcare conference.
  • Opportunity to showcase innovative technology.
  • Potential to improve patient quality of life.

Full Press Release Details

Pulse Biosciences, Inc. (Nasdaq: PLSE), the company leveraging its ever evolving novel and proprietary Nanosecond Pulsed Field Ablation™ (nano-PFA or nsPFA™) technology, today announced plans to participate in the upcoming Piper Sandler 38th Annual Healthcare Conference in New York, NY.
Pulse Biosciences’ Management is scheduled to present on Thursday, December 3, at 8:50 am ET. A live and recorded webcast of the presentation will be available on the “Events Calendar and Presentations” page of the company’s investor website at http://investors.pulsebiosciences.com/.
About Pulse Biosciences®
Pulse Biosciences is a novel bioelectric medicine company committed to health innovation that has the intention as well as potential to improve the quality of life for patients. The Company’s proprietary nPulse™ technology delivers nanosecond pulses of electrical energy to non-thermally clear cells while sparing adjacent non-cellular tissue. The Company is actively pursuing the development of its nPulse technology for use in the treatment of atrial fibrillation and in a select few other markets where it could have a profound positive impact on healthcare for both patients and providers.
Pulse Biosciences, nPulse, Vybrance, CellFX, Nano-Pulse Stimulation, NPS, nsPFA, CellFX nsPFA and the stylized logos are among the trademarks and/or registered trademarks of Pulse Biosciences, Inc. in the United States and other countries.

Frequently Asked Questions

When is Pulse Biosciences presenting?

The presentation is scheduled for December 3 at 8:50 am ET.

Where can I watch the presentation?

The presentation will be available on the company's investor website.

What technology will be showcased?

Pulse Biosciences will showcase its proprietary nano-PFA technology.

What is the focus of Pulse Biosciences?

The company focuses on bioelectric medicine to improve patient quality of life.

Last updated: Nov 19, 2026